drugset / Trial / NCT06447779
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of the sutdy is to evaluate efficacy, safety and immunogenicity of Recombinant Zoster Vaccine (CHO Cell) with 2 doses at 2-month interval in adults aged 40 years and older.
Timeline
- Start
- 2024-07-13
- Primary completion
- 2025-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Zoster Vaccine (CHO Cell) | Vaccine | 50 ug | Intramuscular |
| Subject | Recombinant Zoster Vaccine (CHO Cell) | Vaccine | 0.5 ml | Intramuscular |